Sbir topic 307 phase i novel imaging agents to expand the clinical toolkit for cancer diagnosis, staging, and
Ended Definitive Contract Awarded Last action
- Contract number
- HHSN261201100118C
- Awardee
-
Akrotome Imaging, Inc. UEI KM31KGPYM8Y1
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $249,912
Award facts
- Contract value 100% obligated
- $249,912.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 16 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Menlo Park, CA 94025, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $249,912 |
About this award
This is a Phase I Small Business Innovation Research (SBIR) contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health, to Akrotome Imaging, Inc. The $249,912 Firm-Fixed-Price contract supports the development of novel imaging agents to expand the clinical toolkit for cancer diagnosis, staging, and surgical guidance. The contract is focused on creating a fluorescence imaging probe that can be topically applied in the surgical cavity following lumpectomy procedures to identify residual cancerous tissue that may require further excision. This effort aims to reduce positive surgical margins and cancer recurrence rates for breast cancer patients undergoing breast-conserving surgery. Akrotome Imaging, a small business, has also received prior and subsequent grant funding from NCI and as a subawardee to advance this intraoperative imaging platform and associated imaging agents.
Quick answers
Who was awarded contract HHSN261201100118C?
HHSN261201100118C was awarded to Akrotome Imaging, Inc. by National Cancer Institute (National Institutes of Health) on September 30, 2011.
How much is contract HHSN261201100118C worth?
The government has obligated $249,912 on HHSN261201100118C.
Was contract HHSN261201100118C competed?
The extent of competition for HHSN261201100118C was full and open competition after exclusion of sources. The government received 16 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award